Skip to content

Beneficient BENF Impairment of strategic investments

Impairment of strategic investments at other companies

Gray Television logo
Gray TelevisionGTN
$5M-20.0%
Beneficient logo
BeneficientBENF
$0
USANA Health Sciences logo
USANA Health SciencesUSNA
$0
Energy Vault Holdings logo
Energy Vault HoldingsNRGV
$0-100%
DHI Group logo
DHI GroupDHX
$23K+136%
VirnetX Holding Corp
 logo
VirnetX Holding Corp VHC
$500K

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,022%
Enterprise value$145.33M+40.7%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's impairment of strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's impairment of strategic investments?
Beneficient (BENF) reported impairment of strategic investments of $0 in Q4 2025.
What does impairment of strategic investments mean?
Reflects the impairment charges taken on strategic equity investments that do not have a readily determinable fair value. This metric highlights the loss in value of long-term holdings due to adverse changes in the investee's business performance or market conditions. It serves as a measure of the risk associated with the company's private or non-marketable investment portfolio.